Supportive Care in Low-Risk Myelodysplastic Syndromes: Role of Erythropoiesis Stimulating Agents (ESAs)

被引：0
|
作者：
Cerchione, Claudio [1 ]
Alfinito, Fiorella [2 ]
Giannini, Benedetta Maria [1 ]
Pane, Fabrizio [2 ]
Musuraca, Gerardo [1 ]
Martinelli, Giovanni [1 ]
机构：
[1] IRCCS, Hematol Unit, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, FC, Italy
[2] AOU Federico II, Naples, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
MDS; myelodysplastic syndromes; ESAS; supportive; care; erythropoietin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-502
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [21] The role of rHuEpo in low-risk myelodysplastic syndrome patients
    Rigolin, GM
    Castoldi, G
    LEUKEMIA & LYMPHOMA, 2005, 46 (06) : 823 - 831
  • [22] Supportive Care for Patients With Myelodysplastic Syndromes
    Stempel, Jessica M.
    Podoltsev, Nikolai A.
    Dosani, Talib
    CANCER JOURNAL, 2023, 29 (03) : 168 - 178
  • [23] Clinical Use of Erythropoietic Stimulating Agents in Myelodysplastic Syndromes
    Santini, Valeria
    ONCOLOGIST, 2011, 16 : 35 - 42
  • [24] Efficacy of granulocyte colony stimulating factor in combination with erythropoiesis stimulating agents for treatment of anemia in patients with lower risk myelodysplastic syndromes: A systematic review
    Affentranger, Lucas
    Bohlius, Julia
    Hallal, Mahmoud
    Bonadies, Nicolas
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 136 : 37 - 47
  • [25] Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes
    Gianelli, Umberto
    Fracchiolla, Nicola Stefano
    Cortelezzi, Agostino
    Pellegrini, Caterina
    Savi, Federica
    Moro, Alessia
    Grimoldi, Maria Grazia
    Deliliers, Giorgio Lambertenghi
    Coggi, Guido
    Bosari, Silvano
    ANNALS OF HEMATOLOGY, 2007, 86 (03) : 185 - 189
  • [26] Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes
    Umberto Gianelli
    Nicola Stefano Fracchiolla
    Agostino Cortelezzi
    Caterina Pellegrini
    Federica Savi
    Alessia Moro
    Maria Grazia Grimoldi
    Giorgio Lambertenghi Deliliers
    Guido Coggi
    Silvano Bosari
    Annals of Hematology, 2007, 86 : 185 - 189
  • [27] Thrombopoiesis-stimulating agents and myelodysplastic syndromes
    Brierley, Charlotte K.
    Steensma, David P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (03) : 309 - 323
  • [28] The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data
    Aslaner, Muzeyyen
    Geduk, Ayfer
    Acar, Ibrahim Halil
    Polat, Merve Gokcen
    Sunu, Cenk
    Bolaman, Ali Zahit
    Hacibekiroglu, Tugba
    Guvenc, Birol
    Ertop, Sehmus
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S358 - S358
  • [29] Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study
    Francesco Buccisano
    Anna Lina Piccioni
    Carolina Nobile
    Marianna Criscuolo
    Pasquale Niscola
    Caterina Tatarelli
    Luana Fianchi
    Nicoletta Villivà
    Benedetta Neri
    Ida Carmosino
    Svitlana Gumenyuk
    Stefano Mancini
    Maria Teresa Voso
    Luca Maurillo
    Massimo Breccia
    Gina Zini
    Adriano Venditti
    Susanna Fenu
    Maria Antonietta Aloe Spiriti
    Roberto Latagliata
    Annals of Hematology, 2016, 95 : 1059 - 1065
  • [30] Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study
    Buccisano, Francesco
    Piccioni, Anna Lina
    Nobile, Carolina
    Criscuolo, Marianna
    Niscola, Pasquale
    Tatarelli, Caterina
    Fianchi, Luana
    Villiva, Nicoletta
    Neri, Benedetta
    Carmosino, Ida
    Gumenyuk, Svitlana
    Mancini, Stefano
    Voso, Maria Teresa
    Maurillo, Luca
    Breccia, Massimo
    Zini, Gina
    Venditti, Adriano
    Fenu, Susanna
    Spiriti, Maria Antonietta Aloe
    Latagliata, Roberto
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1059 - 1065
12345